Mitochondria transcription and cancer

Tang Lei,Yu Rui,Zhou Xiaoshuang,Zhang Jinglan,Zhang Jihong

DOI: https://doi.org/10.1038/s41420-024-01926-3

2024-04-09

Cell Death Discovery

Abstract:Mitochondria are major organelles involved in several processes related to energy supply, metabolism, and cell proliferation. The mitochondria function is transcriptionally regulated by mitochondria DNA (mtDNA), which encodes the key proteins in the electron transport chain that is indispensable for oxidative phosphorylation (OXPHOS). Mitochondrial transcriptional abnormalities are closely related to a variety of human diseases, such as cardiovascular diseases, and diabetes. The mitochondria transcription is regulated by the mtDNA, mitochondrial RNA polymerase (POLRMT), two transcription factors (TFAM and TF2BM), one transcription elongation (TEFM), and one known transcription termination factor (mTERFs). Dysregulation of these factors directly leads to altered expression of mtDNA in tumor cells, resulting in cellular metabolic reprogramming and mitochondrial dysfunction. This dysregulation plays a role in modulating tumor progression. Therefore, understanding the role of mitochondrial transcription in cancer can have implications for cancer diagnosis, prognosis, and treatment. Targeting mitochondrial transcription or related pathways may provide potential therapeutic strategies for cancer treatment. Additionally, assessing mitochondrial transcriptional profiles or biomarkers in cancer cells or patient samples may offer diagnostic or prognostic information.

cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the relationship between mitochondrial transcription and cancer. Specifically, the authors focus on the following aspects:

1. **The role of mitochondrial transcription factors in cancer**: Investigating the changes in expression and function of mitochondrial transcription factors (such as TFAM, POLRMT, TFB2M, and MTERFs) in tumor cells, and how these changes affect tumor development and progression.

2. **The relationship between mitochondrial transcription abnormalities and metabolic reprogramming**: Exploring how mitochondrial transcription abnormalities lead to cellular metabolic reprogramming, particularly the increase in glycolysis and decrease in oxidative phosphorylation, thereby promoting tumor cell survival, proliferation, and treatment resistance.

3. **Mitochondrial transcription as a potential target for cancer diagnosis and therapy**: Evaluating the diagnostic and prognostic value of mitochondrial transcription profiles or biomarkers in cancer cells or patient samples, and exploring potential therapeutic strategies targeting mitochondrial transcription or related pathways.

Through these studies, the authors hope to reveal the molecular mechanisms of mitochondrial transcription in cancer occurrence and development, providing new ideas and methods for cancer diagnosis, prognosis, and treatment.